Occlusive implant compositions
US11278641B2 · kind B2 · utility
3Cited by
68References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 2018 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Apr 5, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.